The invention relates to oral sustained release composition comprising creatine or a creatine salt or ester. The invention includes compositions with one or more excipients, where at least one excipient is capable of delaying release of the creatine. The invention also includes oral dosage forms having an enteric coating.
本发明涉及包含
肌酸或
肌酸盐或酯的口服缓释组合物。本发明包括含有一种或多种赋形剂的组合物,其中至少一种赋形剂能够延迟
肌酸的释放。本发明还包括具有肠溶衣的口服剂型。